I often say that digital technology has the potential to unlock “magic” in the biopharma industry, to the direct benefit of patients. Sometimes, the magic is not where you would first expect it to be.
Take for example the use of cloud-based data systems in drug regulation. The future use of such systems will obviously require new technical capabilities and standards, but it will also require a cultural shift and a renewed partnership between the industry and regulators. One thing is certain: drug regulation in the cloud could enhance and accelerate regulatory decision-making, and that’s good news for patients. So, let’s team up and make this vision a reality.
Take a look at this interesting article on the topic published this week in Nature Research (Publishing) review: https://lnkd.in/dCJabKH with Sanofi contributors Hilary M Malone PhD and Andrew Robertsonhashtag#digitalhashtag#cloud